De-Pei Kong

615 total citations
10 papers, 275 citations indexed

About

De-Pei Kong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, De-Pei Kong has authored 10 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in De-Pei Kong's work include Cancer-related molecular mechanisms research (3 papers), Prostate Cancer Treatment and Research (2 papers) and Synthesis and bioactivity of alkaloids (1 paper). De-Pei Kong is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Prostate Cancer Treatment and Research (2 papers) and Synthesis and bioactivity of alkaloids (1 paper). De-Pei Kong collaborates with scholars based in China. De-Pei Kong's co-authors include Guangan Xiao, Yinghao Sun, Chen Ye, Tie Zhou, Rui Chen, Xiaoyuan Zi, Qinqin Tian, Haisong Tan, Xiaolei Shi and Liujun Wang and has published in prestigious journals such as Environmental Pollution, Biochemical Pharmacology and European Urology.

In The Last Decade

De-Pei Kong

10 papers receiving 273 citations

Peers

Countries citing papers authored by De-Pei Kong

Since Specialization

Citations

This map shows the geographic impact of De-Pei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De-Pei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De-Pei Kong more than expected).

Fields of papers citing papers by De-Pei Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De-Pei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De-Pei Kong. The network helps show where De-Pei Kong may publish in the future.

Co-authorship network of co-authors of De-Pei Kong

This figure shows the co-authorship network connecting the top 25 collaborators of De-Pei Kong. A scholar is included among the top collaborators of De-Pei Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De-Pei Kong. De-Pei Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	DEHP-mediated oxidative stress leads to impaired testosterone synthesis in Leydig cells through the cAMP/PKA/SF-1/StAR pathway 2024 ·Environmental Pollution ·Luchen Yang, Shengzhuo Liu, Pan Song, Zhenghuan Liu, Zhufeng Peng, De-Pei Kong, Jing Zhou, (unknown), (unknown), (unknown), Xiaoyang Liu, Qiang Dong	6
2	Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer 2023 ·Journal of Experimental & Clinical Cancer Research ·De-Pei Kong, Chen Ye, Chenxi Zhang, Xiaochen Sun, Fubo Wang, Rui Chen, Guangan Xiao, Shipeng He, Jianrong Xu, (unknown), Jianzhong Ai, Xu Gao, Hong Li, Li Su	7
3	Gelsevirine improves age-related and surgically induced osteoarthritis in mice by reducing STING availability and local inflammation 2022 ·Biochemical Pharmacology ·(unknown), De-Pei Kong, (unknown), (unknown), Juan Lv, (unknown), Nanning Lv, (unknown), Dagui Chen, Mingming Liu, Yongsheng Yu, Li Su	27
4	Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents 2020 ·Biomedicine & Pharmacotherapy ·Li Su, Ye Tu, De-Pei Kong, Dagui Chen, Chenxi Zhang, Wannian Zhang, Chunlin Zhuang, Zhibin Wang	17
5	Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review 2019 ·Asian Journal of Andrology ·Xu Gao, Yinghao Sun, De-Pei Kong, Rui Chen, Chunlei Zhang, Wei Zhang, Guangan Xiao, Fubo Wang, Na Ta	23
6	Replicate systematic review and meta-analyses on robotic surgery: a quality appraisal and overlap investigation 2019 ·Surgical Endoscopy ·Jin Ji, Han Zhang, Da Xu, Tianyi Zhang, De-Pei Kong, Guangan Xiao, Zhi Cao, Fubo Wang, Xu Gao, Yinghao Sun	3
7	Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases 2018 ·Asian Journal of Andrology ·Zhi‐Yong Liu, Ying-hao SUN, Rui Chen, Lei Wang, Xia Sheng, (unknown), (unknown), (unknown), (unknown), Huizhen Li, Yawei Liu, Guanghua Chen, Chunlei Zhang, De-Pei Kong, Guangan Xiao, Xin Lü, Zhenyu Jia	22
8	The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7 2018 ·European Urology ·Guangan Xiao, Jingjing Yao, De-Pei Kong, Chen Ye, Rui Chen, Li Li, Tao Zeng, Liujun Wang, Wei Zhang, Xiaolei Shi, Tie Zhou, Jing Li, Yue Wang, Chuan Xu, Junfeng Jiang, Yinghao Sun	75
9	The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction 2018 ·Cellular Physiology and Biochemistry ·Chen Ye, Chao Zhang, Hai Huang, Bo Yang, Guangan Xiao, De-Pei Kong, Qinqin Tian, Qixiang Song, Xue Song, Haisong Tan, Yang Wang, Tie Zhou, Xiaoyuan Zi, Yinghao Sun	76
10	Profiling and Bioinformatics Analyses of Differential Circular RNA Expression in Prostate Cancer Cells 2018 ·Future Science OA ·Chunlei Zhang, Jun Xiong, Qi Yang, Ye Wang, Haoqing Shi, Qinqin Tian, Hai Huang, De-Pei Kong, (unknown), Dan Liu, Xu Gao, Xiaoyuan Zi, Yinghao Sun	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact